OMOP Concept 779346
abacavir / dolutegravir / lamivudine Oral Liquid Product
ClassificationDrugRxNorm2598346Clinical Dose Group
Maps from
0
Descendants
4
Valid from
1 Aug 2022
Valid to
31 Dec 2099
OMOP concepts
Concept Lookup Tool
Search 11M+ concepts across SNOMED, RxNorm, ICD-10 & LOINC.
Where it sits in the hierarchy
Ordered by distance - 1 is a direct parent or child.
Broader concepts
(7)Roll up to these when you need a wider cohort.
Narrower concepts
(4)Included automatically when you query with descendants.
- 1abacavir 60 MG / dolutegravir 5 MG / lamivudine 30 MG Tablet for Oral Suspension
- 1abacavir 60 MG / dolutegravir 5 MG / lamivudine 30 MG Tablet for Oral Suspension [Triumeq]
- 1abacavir / dolutegravir / lamivudine Tablet for Oral Suspension
- 1abacavir / dolutegravir / lamivudine Tablet for Oral Suspension [Triumeq]
Get this concept via the API
Resolve abacavir / dolutegravir / lamivudine Oral Liquid Product - and every code that maps to it - over HTTPS, against the current vocabulary release. No downloads, no local database.
curl "https://api.omophub.com/v1/concepts/779346?include_relationships=true" \
-H "Authorization: Bearer $OMOPHUB_API_KEY"Get your free API key3,000 calls/month free · no credit card